Shed vs TMates: Coaching, Pricing, and Doctor Access Compared
Introduction: Shed vs TMates at a glance. Verdict: Choose Shed if you want integrated coaching and a choice of name-brand or compounded GLP-1; choose TMates if you want a flat $199/month compounded semaglutide program with 24/7 U.S. doctor access.
Start Shed 2-Minute Assessment
Shed vs TMates: the core differences
The primary keyword Shed vs TMates summarizes two different approaches. Both offer clinician-reviewed, telehealth GLP-1 programs and both note that compounded medications are not FDA-approved. The most distinctive supported differences are medication choice, pricing model, clinical support style, and how each positions compounded versus name-brand products.
1) Medication options: name-brand plus compounded vs compounded only
Shed explicitly offers both FDA-approved name-brand GLP-1 medications and compounded alternatives on one platform, allowing patients to choose based on budget and preference. Shed states that compounded medications are not FDA-approved and are prepared by a licensed pharmacy based on a provider’s prescription.
TMates focuses on clinically dosed compounded semaglutide formulated in U.S.-based facilities. TMates does not advertise branded Ozempic, Wegovy, or Zepbound and highlights compounded semaglutide as its offering. Both providers include the regulatory note that compounded medications are not reviewed by FDA for safety, effectiveness, or quality.
2) Pricing and transparency
Shed lists starting prices for compounded injections, including compounded semaglutide starting at $199/month and compounded tirzepatide starting at $299/month, and offers 10% off the first month as a limited time offer. Shed also notes that standard pricing is not published and that patients receive a personalized quote after intake; coaching is bundled into the monthly cost.
TMates advertises a flat $199/month price at every dose with no step-up fees as dosage escalates. TMates describes this flat-rate model as transparent budgeting for the full cost of the program and lists variant multi-month pricing on its captured landing page while emphasizing free shipping and cancel anytime terms in its promotional copy.
3) Clinical support: integrated coaching vs 24/7 U.S. doctor access
Shed differentiates itself by pairing medication with continuous coaching integrated into treatment rather than simply issuing a prescription. Shed positions coaching as support through titration, lifestyle changes, and plateaus, and notes coaching is bundled into the monthly cost.
TMates emphasizes 24/7 access to U.S.-based doctors in all 50 states, stating that this is actual physician availability not just messaging support. TMates also highlights virtual check-ins and ongoing medical oversight as part of its approach.
4) Sourcing and formulation
TMates specifies medications are formulated in U.S.-based facilities and stresses clinically dosed compounded semaglutide. Shed does not specify compounding location in the supplied evidence but focuses on providing both name-brand and compounded options.
Quick comparison table
| Criteria | Shed | TMates |
|---|---|---|
| Medication options | Name-brand and compounded GLP-1 | Compounded semaglutide (clinically dosed) |
| Starting price | Compounded semaglutide starting at $199/month; personalized quotes for name-brand | $199/month flat at every dose |
| Clinical support | Continuous integrated coaching bundled with treatment | 24/7 U.S. doctor access and virtual check-ins |
| Shipping and fees | 10% off first month limited time offer; personalized pricing | Free shipping; cancel anytime; flat rate pricing |
| Regulatory note | Compounded medications are not FDA-approved | Compounded medications are not FDA-approved |
Clinical and regulatory context to know
Both providers state that compounded medications are not FDA-approved and are prepared by licensed pharmacies based on a provider’s prescription. Shed also explains that a prescription is issued only after a consultation with a licensed provider who determines whether treatment is appropriate. TMates notes availability is based on medical eligibility and that its model aims to avoid prior-authorization delays.
How to decide: who each provider is best for
Shed is framed as the stronger choice for patients who want more than a prescription: integrated coaching plus the option to choose name-brand or compounded GLP-1. This benefits patients who have struggled on medication alone and want behavioral support alongside treatment. Shed touts a fast 2-minute approval assessment and a 10% first-month offer for new patients.
Start TMates Semaglutide Program
TMates is best for patients who want a straightforward, flat-rate compounded semaglutide program with consistent physician availability. TMates highlights a $199/month flat price at every dose, 24/7 U.S.-based doctor access across all 50 states, U.S.-formulated medications, and virtual check-ins for ongoing oversight.
Explore Shed Medication Options
Summary and final recommendation
In a direct comparison of Shed vs TMates, the key tradeoffs are choice and coaching versus flat-rate compounded pricing and round-the-clock physician access. Both note that compounded products are not FDA-reviewed. Choose Shed if you value integrated coaching and the ability to select name-brand or compounded GLP-1. Choose TMates if you prefer a predictable $199/month price at every dose and 24/7 access to U.S.-based doctors.
Choose Shed if…
- You want both FDA-approved name-brand GLP-1 options and compounded alternatives in one platform.
- You prefer integrated, continuous coaching bundled with treatment rather than prescription-only care.
- You want a quick eligibility check via a 2-minute assessment and a first-month 10% offer.
Choose TMates if…
- You prefer a flat $199/month compounded semaglutide price with no step-up fees as dosage escalates.
- You want 24/7 access to U.S.-based doctors and medications formulated in U.S. facilities.